1. Home
  2. IGIC vs WVE Comparison

IGIC vs WVE Comparison

Compare IGIC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGIC
  • WVE
  • Stock Information
  • Founded
  • IGIC 2001
  • WVE 2012
  • Country
  • IGIC Jordan
  • WVE Singapore
  • Employees
  • IGIC N/A
  • WVE N/A
  • Industry
  • IGIC Property-Casualty Insurers
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • IGIC Finance
  • WVE Health Care
  • Exchange
  • IGIC Nasdaq
  • WVE Nasdaq
  • Market Cap
  • IGIC 1.0B
  • WVE 915.6M
  • IPO Year
  • IGIC N/A
  • WVE 2015
  • Fundamental
  • Price
  • IGIC $22.20
  • WVE $7.37
  • Analyst Decision
  • IGIC Buy
  • WVE Strong Buy
  • Analyst Count
  • IGIC 2
  • WVE 17
  • Target Price
  • IGIC $31.50
  • WVE $20.29
  • AVG Volume (30 Days)
  • IGIC 62.5K
  • WVE 2.3M
  • Earning Date
  • IGIC 11-04-2025
  • WVE 11-11-2025
  • Dividend Yield
  • IGIC 4.72%
  • WVE N/A
  • EPS Growth
  • IGIC 11.00
  • WVE N/A
  • EPS
  • IGIC 2.79
  • WVE N/A
  • Revenue
  • IGIC $535,109,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • IGIC $6.05
  • WVE N/A
  • Revenue Next Year
  • IGIC $7.01
  • WVE $6.26
  • P/E Ratio
  • IGIC $7.97
  • WVE N/A
  • Revenue Growth
  • IGIC 9.99
  • WVE N/A
  • 52 Week Low
  • IGIC $19.04
  • WVE $5.28
  • 52 Week High
  • IGIC $27.76
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • IGIC 38.66
  • WVE 46.43
  • Support Level
  • IGIC $22.03
  • WVE $6.93
  • Resistance Level
  • IGIC $22.61
  • WVE $8.13
  • Average True Range (ATR)
  • IGIC 0.45
  • WVE 0.48
  • MACD
  • IGIC -0.01
  • WVE -0.02
  • Stochastic Oscillator
  • IGIC 19.72
  • WVE 31.88

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: